Filing Flows › Calumet (CLMT) › Q2 2026 › vs Q2 2025
Calumet (CLMT) Q2 2026 vs Q2 2025 (year over year)
Calumet's revenue rose $418M (+41%) from $1.0B in Q2 2025 to $1.4B in Q2 2026.
Calumet, Q2 2026: revenue $1.4B (+41% year over year), operating margin -2.8%, net loss $95.9M, operating cash flow $92.3M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 3.7% | -2.0% | +5.8 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.4B | $1.0B | $418M | +41% |
| Income tax benefit | $21.2M | −$200K | $21.4M | — |
| Net loss | $95.9M | $148M | −$52.0M | -35% |
| Costs & expenses | $1.6B | $1.2B | $388M | +33% |
| Operating costs | $1.5B | $1.1B | $358M | +32% |
| Interest & other, net | $77.1M | $46.7M | $30.4M | +65% |
| Cost of revenue | $1.4B | $1.1B | $357M | +33% |
| Sales & marketing | $13.5M | $12.2M | $1.3M | +11% |
| General & admin | $39.4M | $41.1M | −$1.7M | -4% |
| Other operating costs | $5.4M | $4.1M | $1.3M | +32% |
| Operating cash sources | $188M | $146M | $42.1M | +29% |
| Depreciation & amortization | $34.6M | $36.7M | −$2.1M | -6% |
| Share-based compensation | $7.5M | $4.5M | $3.0M | +67% |
| Working capital & other | $146M | $105M | $41.2M | +39% |
| Net loss absorbed | $95.9M | $148M | −$52.0M | -35% |
| Operating cash flow | $92.3M | −$1.8M | $94.1M | — |
| Free cash flow (OCF − capex) | $54.0M | −$20.8M | $74.8M | — |
| Capital expenditures | $38.3M | $19.0M | $19.3M | +102% |
Questions
How much did Calumet's revenue grow year over year in Q2 2026?
Calumet's revenue rose $418M (+41%) from $1.0B in Q2 2025 to $1.4B in Q2 2026.